US 12,285,399 B2
Composition comprising bornyl acetate or pharmaceutically acceptable salt thereof as active ingredient for prevention or treatment of stress-related disorder
Ik-Hyun Cho, Seoul (KR); and Jong-Hee Choi, Gyeongju-si (KR)
Assigned to UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY, Yongin-si (KR)
Appl. No. 17/439,578
Filed by UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY, Yongin-si (KR)
PCT Filed Mar. 18, 2020, PCT No. PCT/KR2020/003695
§ 371(c)(1), (2) Date Sep. 15, 2021,
PCT Pub. No. WO2020/190024, PCT Pub. Date Sep. 24, 2020.
Claims priority of application No. 10-2019-0030527 (KR), filed on Mar. 18, 2019.
Prior Publication US 2022/0151971 A1, May 19, 2022
Int. Cl. A61K 31/215 (2006.01); A23L 33/10 (2016.01); A61P 25/00 (2006.01)
CPC A61K 31/215 (2013.01) [A61P 25/00 (2018.01)] 5 Claims
 
1. A method for treating depression, the method comprising administering a pharmaceutically effective amount of a composition comprising bornyl acetate or a pharmaceutically acceptable salt thereof as an active ingredient to a subject in need thereof.